Climb Bio Inc. (CLYM)
NASDAQ: CLYM
· Real-Time Price · USD
2.33
-0.11 (-4.51%)
At close: Sep 04, 2025, 3:59 PM
2.38
2.15%
Pre-market: Sep 05, 2025, 09:05 AM EDT
-4.51% (1D)
| Bid | 2.31 |
| Market Cap | 157.89M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -46.76M |
| EPS (ttm) | -0.02 |
| PE Ratio (ttm) | -116.5 |
| Forward PE | -3.3 |
| Analyst | Buy |
| Ask | 2.36 |
| Volume | 390,239 |
| Avg. Volume (20D) | 502,398 |
| Open | 2.45 |
| Previous Close | 2.44 |
| Day's Range | 2.26 - 2.46 |
| 52-Week Range | 1.05 - 8.79 |
| Beta | -0.10 |
About CLYM
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CLYM
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CLYM stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 months ago
+12.1%
Climb Bio shares are trading higher after Oppenhei...
Unlock content with
Pro Subscription
9 months ago
+7.12%
Climb Bio shares are trading higher. The company announced it appointed a new chair to its board of directors.
